Molecular Dynamics Simulation Software Market - Regional Analysis
North America Market Insights
The North America industry is expected to account for largest revenue share of 47% by 2035. The growth of the market in this region can be attributed to a large-scale adoption of cutting-edge technology and an increase in private funding for molecular dynamics research. Additionally, there has been growing investment made on R&D by pharmaceutical sector in North America. In the last two decades, there has been a surge in both R&D spending and the release of new medications in this region. The pharmaceutical sector invested USD 83 billion in research and development in 2019. That sum is roughly ten times what the sector spent annually in the 1980s after accounting for inflation. Also, in comparison to the prior decade, the number of new pharmaceuticals licensed for sale increased by 60% between 2010 and 2019, reaching a peak of 59 new drugs approved in 2018. Hence, this factor is estimated to boost the growth of the market in this region. However, the market in Europe region is anticipated to grow at a highest CAGR of 10.54% over the forecast period.
